Kevin Alexander

3.6k total citations · 1 hit paper
67 papers, 1.3k citations indexed

About

Kevin Alexander is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Kevin Alexander has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 10 papers in Cardiology and Cardiovascular Medicine and 10 papers in Epidemiology. Recurrent topics in Kevin Alexander's work include Amyloidosis: Diagnosis, Treatment, Outcomes (28 papers), Parathyroid Disorders and Treatments (9 papers) and Peptidase Inhibition and Analysis (6 papers). Kevin Alexander is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (28 papers), Parathyroid Disorders and Treatments (9 papers) and Peptidase Inhibition and Analysis (6 papers). Kevin Alexander collaborates with scholars based in United States, Canada and Indonesia. Kevin Alexander's co-authors include Rodney H. Falk, Ronglih Liao, Sharmila Dorbala, Avinainder Singh, A Creutzig, L Caspary, Ronald Witteles, Paul Cheng, Sophia Jacob and Norrisa Haynes and has published in prestigious journals such as JAMA, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Kevin Alexander

54 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

AL (Light-Chain) Cardiac Amyloidosis

2016 404 citations Rodney H. Falk, Kevin Alexander et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Kevin Alexander

Since Specialization

Citations

This map shows the geographic impact of Kevin Alexander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Alexander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Alexander more than expected).

Fields of papers citing papers by Kevin Alexander

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Alexander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Alexander. The network helps show where Kevin Alexander may publish in the future.

Co-authorship network of co-authors of Kevin Alexander

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Alexander. A scholar is included among the top collaborators of Kevin Alexander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Alexander. Kevin Alexander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy 2025 ·Journal of the American College of Cardiology ·Daniel P. Judge, Kevin Alexander, Francesco Cappelli, (unknown), Pablo García‐Pavía, Simon Gibbs, Martha Grogan, Mazen Hanna, Ahmad Masri, Mathew S. Maurer, Laura Obici, Prem Soman, Xiaofan Cao, Ted Lystig, Jean‐François Tamby, Suresh Siddhanti, Adam Castaño, Leonid Katz, Jonathan C. Fox, (unknown), Julian D. Gillmore	7
2	Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial 2025 ·Circulation ·Marianna Fontana, Pablo García‐Pavía, Martha Grogan, Sanjiv J. Shah, Mads D.M. Engelmann, G. Kees Hovingh, Arnt V. Kristen, (unknown), (unknown), (unknown), (unknown), Nitasha Sarswat, Kenichi Tsujita, Kevin Alexander, Mathew S. Maurer	0
3	ACORAMIDIS IMPROVES SERUM TTR LEVELS IN PATIENTS WITH WILD-TYPE OR VARIANT TRANSTHYRETIN AMYLOID CARDIOMYOPATHY 2025 ·Journal of the American College of Cardiology ·Margot K. Davis, Kevin Alexander, Amrut V. Ambardekar, Daniel P. Judge, (unknown), (unknown), Michel G. Khouri, Richard K. Cheng, Richard F. Wright, Robert Gordon, (unknown), Suresh Siddhanti, (unknown), Jonathan C. Fox, Alan X. Ji, Uma Sinha, Julian D. Gillmore, Mathew S. Maurer	0
4	Should We Systematically Screen for the Amyloidogenic V142I Variant? 2024 ·Journal of Cardiac Failure ·Jessica A. Regan, Michel G. Khouri, (unknown), Kevin Alexander, Sadiya S. Khan, Svati H. Shah, Senthil Selvaraj	2
5	Nurturing Diverse Generations of the Medical Workforce for Success With Authenticity: An Association of Black Cardiologists’ Roundtable 2023 ·Circulation Cardiovascular Quality and Outcomes ·Norrisa Haynes, Michelle N. Johnson, Sabra C. Lewsey, Kevin Alexander, D. Edmund Anstey, (unknown), Joyce Njoroge, Debra B. Gordon, Elizabeth Ofili, Clyde W. Yancy, Michelle A. Albert	1
6	Implications of Extra-cardiac Disease in Patient Selection for Heart Transplantation: Considerations in Cardiac Amyloidosis 2023 ·Cardiac failure review ·Lynn Punnoose, Hasan K. Siddiqi, Julie Rosenthal, M. Kittleson, Ronald Witteles, Kevin Alexander	1
7	FREEDOM OF CONTRACT IN MORTGAGE LOAN AGREEMENT AT PT. BANK CIMB NIAGA, TBK. IN MEDAN 2022 ·(unknown), (unknown), Kevin Alexander	0
8	Development of low-cost edible coatings based on polysaccharides with active lactic acid bacteria for the protection of fresh produce modeled using fresh cut apples 2022 ·Food Science and Technology International ·Joni Kusnadi, (unknown), (unknown), (unknown), (unknown), Kevin Alexander	8
9	Self-referencing ultrasound detection of fiber Bragg grating sensor with two adhesive bonds 2021 ·Measurement Science and Technology ·(unknown), Kevin Alexander, Kara Peters	4
10	Racial and Ethnic Disparities in Transthyretin Cardiac Amyloidosis 2021 ·Current Cardiovascular Risk Reports ·Gabriela Spencer‐Bonilla, Joyce Njoroge, (unknown), Ronald Witteles, Mandar A. Aras, Kevin Alexander	17
11	Serum high-density lipoprotein cholesterol serves as a prognostic marker for light-chain cardiac amyloidosis 2020 ·International Journal of Cardiology ·(unknown), Ke Wan, (unknown), Xinli Guo, Yuanwei Xu, Jie Wang, Qing Zhang, Kevin Alexander, Ronglih Liao, Yucheng Chen	3
12	High-Frequency Ultrasound Echocardiography to Assess Zebrafish Cardiac Function 2020 ·Journal of Visualized Experiments ·(unknown), Katharina Schimmel, (unknown), (unknown), Sudeshna Fisch, Kevin Alexander, Ronglih Liao, Isabel Morgado	10
13	Emerging Therapies for Transthyretin Cardiac Amyloidosis 2019 ·Current Treatment Options in Cardiovascular Medicine ·Kevin Alexander, (unknown), Ronald Witteles	7
14	Diagnosis and Treatment of Cardiac Amyloidosis Related to Plasma Cell Dyscrasias 2019 ·Cardiology Clinics ·Kevin Alexander, (unknown), Ronald Witteles	4
15	Mortality From Heart Failure and Dementia in the United States: CDC WONDER 1999–2016 2018 ·Journal of Cardiac Failure ·Jacqueline Vuong, Sophia Jacob, Kevin Alexander, Avinainder Singh, Ronglih Liao, Akshay S. Desai, Sharmila Dorbala	22
16	Abstract 17099: Mortality From Heart Failure and Dementia in the United States: Centers for Disease Control (CDC) WONDER 1999 to 2015 2017 ·Circulation ·Jacqueline Vuong, Sophia Jacob, Kevin Alexander, Avinainder Singh, Ronglih Liao, Akshay S. Desai, Sharmila Dorbala	1
17	Phosphorylation of Src by phosphoinositide 3-kinase regulates beta-adrenergic receptor-mediated EGFR transactivation 2016 ·Cellular Signalling ·Lewis J. Watson, Kevin Alexander, Maradumane L. Mohan, Amber L. Bowman, Supachoke Mangmool, Kunhong Xiao, Sathyamangla V. Naga Prasad, Howard A. Rockman	21
18	ANALISA KARAKTERISTIK DAN APLIKASI CAMPURAN ASPAL EMULSI DINGIN DENGAN SPESIFIKASI CAMPURAN ASPAL PANAS 2016 ·Kevin Alexander, (unknown), (unknown), (unknown)	1
19	AL (Light-Chain) Cardiac Amyloidosis breakdown → 2016 ·Journal of the American College of Cardiology ·Rodney H. Falk, Kevin Alexander, Ronglih Liao, Sharmila Dorbala	404
20	Schema Based XML Compression 2007 ·Naphtali Rishe, Ouri Wolfson, (unknown), (unknown), (unknown), (unknown), Ricardo Koller, (unknown), (unknown), Kevin Alexander, Malek Adjouadi	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact